2023 articles
- ESC 2022 Cardio-Oncology Guidelines: Paving the way for cardiovascular care through the minefield of cardiotoxicity in cancer survivorship ( 28/07/2023 )
- Breaking the Barrier: The Benefits and Drawbacks of TAVI in Low-Surgical Risk Patients ( 18/07/2023 )
- The first ESC cardio-oncology guidelines: Key messages for prevention of bleeding and thromboembolic events in cancer patients ( 31/05/2023 )
- What is the effect of an interventional career on musculoskeletal health? A trainee’s perspective ( 03/05/2023 )
- Factor XI Inhibitors: the Future of Anticoagulation in Atrial Fibrillation? ( 01/05/2023 )
- Early repolarisation – benign or early sign? ( 14/04/2023 )
- Wearable cardiac monitoring: where are we now and where are we going? ( 05/04/2023 )
- Conduction System Pacing: The future of pacing? ( 05/04/2023 )
- Atrial fibrillation: time to personalise the ablation approach? ( 27/02/2023 )
- The power of one versus many ( 27/02/2023 )
- Coronary Revascularisation in Severe Ischaemic Cardiomyopathy - To Stent or Not to Stent? ( 27/02/2023 )
- Sodium-glucose Co-transporter-2 (SGLT2) inhibitors and use in patients with acute coronary syndromes: The 5th Paradigm shift? ( 21/02/2023 )
Community Events Calendar
